Market Cap
$31.4M
SRXH
SRX Global Inc.
$1.61 ▲ +3.87%
Prev close $1.55Market cap$31.4M
High Impact Filing (7/10)4 New Institutional Positions Consumer & Retail
Snapshot
The big-picture read on SRXH right now — valuation, ownership and activity at a glance.
Cap Size
Nano Cap
Inst. Holders
11 funds
Inst. Value
$145.4K
Inst. Activity
4 buys / 0 sells
Social Sentiment
68° Warm
SEC Reports
13
Press Releases
11
Price chart 30d +3.2%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 earnings_calendar
Sep 9, 2026 SEC SRXH Q4 2026 Earnings After Market Close — 2026-09-30
SRX Global Inc. obtained consent from the holders of its Series C convertible preferred stock to implement a stock repur
8-K — Impact 3/10
SRX Global Inc. (SRXH) entered into a secured debt financing transaction with CERo Therapeutics Holdings, Inc. (CERO), a
8-K — Impact 5/10
SRX Global issued $2.86M of Series C convertible preferred stock to accredited investors in exchange for assignment of C
8-K — Impact 5/10
SRX Global Inc. (SRXH) announced it has acquired a stake in Vistagen Therapeutics (VTGN), a late clinical-stage biopharm
Impact 6/10
SRX Global announced that its portfolio company Smartkem, Inc. (NASDAQ: SMTK) will merge with Ferrox Critical Minerals.
Impact 4/10
Jun 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — DOUBLED
6,994,141 shares ($634.4K)
Jun 30, 2026 Inst.
JANE STREET GROUP, LLC — DOUBLED
3,379,608 shares ($307.5K)
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2025 | 2 | 4 | 1 | 0 | 0 | 86% |
Social media sentiment mood -21.7%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
68°
Warm
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
13 SEC filing reports analyzed · 1 bullish, 3 bearish, 2 mixed, 7 neutral · avg impact 4.7/10.Plus 11 press releases.
NEUTRAL8-K3/10
SRX Global Inc. obtained consent from the holders of its Series C convertible preferred stock to imp
Sep 9, 2026
NEUTRAL8-K5/10
SRX Global Inc. (SRXH) entered into a secured debt financing transaction with CERo Therapeutics Hold
Sep 2, 2026
BEARISH8-K5/10
SRX Global issued $2.86M of Series C convertible preferred stock to accredited investors in exchange
Aug 28, 2026
MIXED8-K5/10
SRX Global reported fiscal Q3 2026 results with net sales up 27% YoY to $3.4M, operating loss improv
Aug 19, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 30, 2026
earnings_calendar
SRXH Q4 2026 Earnings After Market Close — 2026-09-30
Sep 28, 2026
earnings_calendar
SRXH Q4 2026 Earnings After Market Close — 2026-09-28
Sep 24, 2026
activist
SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
SRX has added ONCO in anticipation of Realbotix LLC acquisition closing. Believes Vinci AI Vision system is extremely undervalued and misunderstood, w
Sep 23, 2026
other
SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment Webinar
NORTH PALM BEACH, Fla., Sept. 23, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company” or “SRX”), an AI-enabled platform dedi
Sep 14, 2026
short_volume
Short Volume: SRXH — 56.7% short (0.3M / 0.5M)
Short: 300,474 | Exempt: 2,358 | TRF Vol: 530,269 | Short Ratio: 56.7% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Current FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
Institutional ownership
Which big funds own SRXH (from quarterly 13F filings) and who is adding or trimming.
11 institutional holders with $145.4K total value (1,128,455 shares) as of 2026-Q1. Top holders: ROYAL, JANE, GEODE. Net buying activity: 3 institutions added/increased vs 0 reduced.
Top holders — 2026-Q1
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| ROYAL BANK OF CANADA | 1,296 | $0.00 | 0.0% | — |
| JANE STREET GROUP, LLC | 595,228 | $76.8K | 52.8% | DOUBLED +467.8% |
| GEODE CAPITAL MANAGEMENT, LLC | 247,456 | $31.9K | 22.0% | DOUBLED +2726.4% |
| SCOTIA CAPITAL INC. | 108,132 | $13.9K | 9.6% | DOUBLED +500.7% |
| UBS Group AG | 85,742 | $11.1K | 7.6% | DOUBLED +510.8% |
| MORGAN STANLEY | 34,000 | $4.4K | 3.0% | — |
| Rathbones Group PLC | 20,000 | $2.6K | 1.8% | — |
| Fisher Asset Management, LLC | 20,000 | $2.6K | 1.8% | — |
| Sanctuary Advisors, LLC | 13,800 | $1.8K | 1.2% | — |
| CITIGROUP INC | 2,710 | $350.00 | 0.2% | DOUBLED +19111.0% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | DOUBLED | 247,456 | 6,994,141 | +2726.4% | $634.4K |
| JANE STREET GROUP, LLC | DOUBLED | 595,228 | 3,379,608 | +467.8% | $307.5K |
| UBS Group AG | DOUBLED | 85,742 | 523,731 | +510.8% | $47.7K |
| CITIGROUP INC | DOUBLED | 2,710 | 520,619 | +19111.0% | $47.2K |
| GEODE CAPITAL MANAGEMENT, LLC | DOUBLED | 114,679 | 247,456 | +115.8% | $31.9K |
| SCOTIA CAPITAL INC. | DOUBLED | 18,000 | 108,132 | +500.7% | $13.9K |
| UBS Group AG | ADD | 43,035 | 85,742 | +99.2% | $11.1K |
| VANGUARD GROUP INC | ADD | 156,724 | 280,730 | +79.1% | $64.0K |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | 72,301 | 114,679 | +58.6% | $26.2K |
| UBS Group AG | DOUBLED | 396 | 43,035 | +10767.4% | $9.8K |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
2 insiders, 11 transactions. Net $0.00 — $0.00 bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Cunningham Kent Douglas | Chief Executive Officer | AWARD | 63 | $800.00 | $50.4K |
| Mar 16, 2026 | Cunningham Kent Douglas | Chief Executive Officer | AWARD | 247,522 | $0.3182 | $78.8K |
| Dec 3, 2025 | Cunningham Kent Douglas | Chief Executive Officer | AWARD | 200,000 | $0.3900 | $78.0K |
| Dec 3, 2025 | Conway Simon Alexander Malcolm | Director | AWARD | 630,000 | $0.3900 | $245.7K |
| Sep 26, 2025 | Cunningham Kent Douglas | Chief Executive Officer | AWARD | 44,464 | $0.3300 | $14.7K |
| Aug 25, 2025 | Conway Simon Alexander Malcolm | Director | AWARD | 154,128 | $0.4000 | $61.7K |
| Aug 25, 2025 | Cunningham Kent Douglas | Chief Executive Officer | AWARD | 231,193 | $0.4040 | $93.4K |
| Apr 25, 2025 | Cunningham Kent Douglas | Chief Executive Officer | AWARD | 84,906 | $1.59 | $135.0K |
| Apr 24, 2025 | Cunningham Kent Douglas | Chief Executive Officer | AWARD | 71,770 | $2.09 | $150.0K |
| Jun 26, 2024 | Cunningham Kent Douglas | Chief Executive Officer | AWARD | 22,727 | $4.17 | $94.8K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for SRXH.
Shares short
1,669,769
Settlement Sep 15, 2026
Change vs prior
+9.5%
Semi-monthly cycle
Days to cover
2.8
At avg daily volume
Of shares outstanding
≈8.2%
Estimate — not % of float
| Halted | Code | Reason | Status |
|---|---|---|---|
| Jul 9, 2026 | M | Volatility Pause | Resumed |
| Jul 9, 2026 | T1 | News Pending | Not resumed |
| Jul 9, 2026 | T3 | Resumption Scheduled | Resumed |
| Jul 8, 2026 | T1 | News Pending | Not resumed |
| Jul 8, 2026 | T3 | Resumption Scheduled | Resumed |
All SRXH filing & press-release reports (24)
- 8-K reportSep 9, 2026
- 8-K reportSep 2, 2026
- 8-K reportAug 28, 2026
- 8-K reportAug 19, 2026
- PRESS-RELEASE reportAug 4, 2026
- PRESS-RELEASE reportAug 3, 2026
- PRESS-RELEASE reportJul 30, 2026
- 8-K reportJul 28, 2026
- 8-K reportJul 16, 2026
- PRESS-RELEASE reportJul 16, 2026
- 8-K reportJul 15, 2026
- 8-K reportJun 26, 2026
- 8-K reportJun 18, 2026
- PRESS-RELEASE reportJun 18, 2026
- PRESS-RELEASE reportJun 8, 2026
- PRESS-RELEASE reportMay 29, 2026
- EFFECT reportMay 8, 2026
- 8-K reportApr 22, 2026
- 8-K reportApr 17, 2026
- PRESS-RELEASE reportApr 16, 2026
- PRESS-RELEASE reportApr 7, 2026
- PRESS-RELEASE reportMar 25, 2026
- PRESS-RELEASE reportMar 18, 2026
- 8-K reportMar 3, 2026